D-0636-2024 Class II Ongoing
FDA drug recall D-0636-2024 was initiated by Fagron Compounding Services on August 15, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing.
Recall Details
- Product Type
- Drugs
- Report Date
- August 28, 2024
- Initiation Date
- August 15, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
Product Description
Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide in the USA
Code Information
Lot#: C274-000037397, C274-000037398, C274-000037399, C274-000037400, Exp. Date 10/14/2024.